This nationwide analysis of registered Alport syndrome cases suggests potential underdiagnosis in Korea, with delays in appropriate recognition and treatment. Many patients receive unnecessary immunosuppression due to misdiagnosis, underscoring the need for improved diagnostic awareness and broader genetic testing.
Park et al. (Thu,) studied this question.